Correlation Between Atmos Energy and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Atmos Energy and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atmos Energy and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atmos Energy and Spyre Therapeutics, you can compare the effects of market volatilities on Atmos Energy and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atmos Energy with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atmos Energy and Spyre Therapeutics.

Diversification Opportunities for Atmos Energy and Spyre Therapeutics

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Atmos and Spyre is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Atmos Energy and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Atmos Energy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atmos Energy are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Atmos Energy i.e., Atmos Energy and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Atmos Energy and Spyre Therapeutics

Considering the 90-day investment horizon Atmos Energy is expected to generate 14.72 times less return on investment than Spyre Therapeutics. But when comparing it to its historical volatility, Atmos Energy is 18.41 times less risky than Spyre Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  323.00  in Spyre Therapeutics on August 31, 2024 and sell it today you would earn a total of  2,520  from holding Spyre Therapeutics or generate 780.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Atmos Energy  vs.  Spyre Therapeutics

 Performance 
       Timeline  
Atmos Energy 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Atmos Energy are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Atmos Energy displayed solid returns over the last few months and may actually be approaching a breakup point.
Spyre Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Atmos Energy and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Atmos Energy and Spyre Therapeutics

The main advantage of trading using opposite Atmos Energy and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atmos Energy position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind Atmos Energy and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Directory
Find actively traded commodities issued by global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm